POSTER SESSION II
Monday, March 3, 2008   —  1:00 PM - 4:30 PM
Convention Center, Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GYNECOLOGIC PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
148 Frequency of PTEN Loss in Benign Endometria of Premenopausal Women: A Preliminary Analysis (923)
E Elishaev, R Guido, D Dabbs, N Chatterjee, J Lacey, Jr., C Mueller, ME Sherman - University of Pittsburgh School of Medicine, Magee Womens Hospital, Pittsburgh, PA; National Cancer Institute, Rockville, MD 		Add
149 Endometrial Intraepithelial Neoplasia Is Associated with Polyps and Frequently Has Metaplastic Change (908)
JW Carlson, GL Mutter - Brigham and Women's Hospital, Boston, MA 		Add
150 Evaluation of p27 as an Endometrial Biomarker of Response to Progestin (1020)
Z Sangale, K Lu, R Broaddus - M.D. Anderson Cancer Center, Houston, TX 		Add
151 Endometrial Polyps with Complex and Complex Atypical Hyperplasia: Follow-Up Findings (967)
R Lee, DA Popiolek - New York University, New York 		Add
152 A Multicentric Prospective Study of Hormonal Therapy for Atypical Endometrial Hyperplasia and Endometrial Carcinoma in Young Women: Histologic Changes and Treatment Outcome (934)
M Fukunaga, K Ushijima, H Yahata, T Kamura, H Yoshikawa, H Tsuda, A Sakamoto - Jikei University Daisan Hospital, Komaeshi, Tokyo, Japan; Kurume University, Kurumeshi, Fukuoka, Japan; Tsukuba University, Tsukubashi, Ibaragi, Japan; National Defense Medical College, Tokorozawashi, Saitama, Japan; Kyorin University, Mitakashi, Tokyo, Japan 		Add
153 Endometrial Cancer Diagnosed in Young Patients Is Not Always a Low-Risk Cancer (900)
S Bandyopadhyay, H Arabi, D Thirabanjasak, MR Quddus, WD Lawrence, R Ali-Fehmi - Wayne State Univ-Harper Hospital, Detroit, MI; Women and Infant's Hospital/The Warren Alpert Medical School of Brown University, Providence, RI 		Add
154 Frequent Lymphovascular Invasion but Not Aggressive Behavior Is Characteristic of Endometrioid Endometrial Carcinomas with "MELF" Features: A Clinicopathologic Study of 22 Cases (988)
E Oliva, G Toledo - Massachusetts General Hospital, Boston, MA 		Add
155 Histological Findings in the Nonmyoinvasive Component of FIGO Grade I Endometrial Endometrioid Adenocarcinoma Associated with Myoinvasion: Analysis of 100 Cases (1001)
DA Popiolek, K Mittal - New York University, New York 		Add
156 Adenocarcinomas of the Lower Uterine Segment: Immunohistochemical Studies of 13 Cases (995)
K Patel, SX Liang, M Pearl, K Park, C Tornos - Stony Brook University Medical Center, Stony Brook; Memorial Sloan-Kettering Cancer Center, New York 		Add
157 Immunoprofile of Mucinous and Microglandular Adenocarcinomas of the Endometrium (915)
MA Chekmareva, L Ellenson, EC Pirog - Weill Medical College of Cornell University, New York, NY 		Add
158 Expression of a Panel of Immunohistochemical Stains in Normal Cervix, Endometrium, and Uterine Carcinomas (1053)
J Zhou, A Khiyami, J Tomashefsky, K Zilch, J Sawady - MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH 		Add
159 Hormone Receptor, Cell Damage, and Proliferative Markers in "Normal" Appearing PTEN-Null Endometrial Glands (918)
YK Chun, GL Mutter - Cheil General Hospital & Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea; Brigham and Women's Hospital, Boston, MA 		Add
160 Mismatch Repair Protein Expression and MSI Status Are Not Related with BRAF V600E Mutation in Endometrial Carcinoma (997)
G Peiro, L Sanchez-Tejada, C Alenda, FM Peiro, A Paya, S Benlloch, FI Aranda - Hospital General Universitari, Alacant, Spain 		Add
161 Epithelial-Mesenchymal Transition (EMT) in Early Stages of Endometrioid Endometrial Carcinomas (980)
N Montserrat, L Catasus, J Pena, A Gallardo, M Cuatrecasas, X Matias-Guiu, J Prat - Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain; Hospital Arnau de Vilanova, University of Lleida, Lleida, Spain 		Add
162 Comparative Study of Maspin Expression in Type I and Type II Endometrial Carcinoma (1025)
D Shi, D Thirabanjasak, S Bandyopadhyay, K Sanjeev, H Arabi, V Schimp, R Morris, A Munkarah, R Ali-Fehmi - Wayne State University, Detroit, MI 		Add
163 Biomarker Clustering Segregates Endometrial Carcinoma into Two Distinct Groups (1042)
S Westin, K Lu, D Loose, R Broaddus - M.D. Anderson Cancer Center, Houston, TX; UT-Houston Medical School, Houston, TX 		Add
164 Are the Endometrial Serous Carcinomas Underdiagnosed? Histomorphologic and Immunohistochemical Correlates in High Grade Endometrial Carcinomas, Initially Diagnosed as High Grade Endometrioid Adenocarcinomas (942)
JL Hinson, ML Cibull, RG Karabakhtsian - University of Kentucky, Lexington, KY 		Add
165 p53 Overexpression in Morphologically Ambiguous Endometrial Carcinomas Correlates with Adverse Clinical Outcomes (939)
K Garg, RA Soslow, MW Guile, MM Leitao, Jr. - MSKCC, New York, NY 		Add
166 Evidence of a Latent Precursor (p53 Signature) to Uterine Serous Carcinoma (950)
A Jarboe, E Pizer, A Miron, CP Crum - Brigham and Women's Hospital, Boston, MA; CellNetix Pathology, Seattle, WA; Dana Farber Cancer Institute, Boston, MA 		Add
167 Molecular Genetic Analysis of High Grade Endometrial Carcinomas (906)
JM Boland, LM Peterson, BR Kipp, DI Smith, GL Keeney, AC Clayton, KC Halling, F Medeiros - Mayo Clinic, Rochester, MN 		Add
168 PIK3CA Mutations and p53 Alterations in High-Grade Endometrial Carcinomas (911)
L Catasus, A Gallardo, M Cuatrecasas, C Pons, J Prat - Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain 		Add